Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: A randomized study in patients undergoing autologous peripheral stem cell transplantation

American Journal of Hematology

Volumn 83, Issue 8, 2008, Pages 644-648

  Ataergin, Selmin ^a   Arpaci, Fikret ^a   Turan, Mustafa ^a   Solchaga, Luis ^b   Cetin, Turker ^a   Ozturk, Mustafa ^a   Ozet, Ahmet ^a   Komurcu, Seref ^a   Ozturk, Bekir ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; BODY SURFACE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENGRAFTMENT; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX; STEM CELL MOBILIZATION; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FILGRASTIM; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOMBINANT PROTEINS; TRANSPLANTATION, AUTOLOGOUS;

EID: 49149089190     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21206     Document Type: Article

References (22)

1. Holloway CJ. Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor. Eur J Cancer 1994;30A(Suppl 3):S2-S6.
2. Saunders G. G-CSFs in daily pharmaceutical practice. Eur J Clin Pharm 2001;3:1-4.
3. Hasegawa M. A thermodynamic model for denaturation of granulocyte colony-stimulating factor: O-linked sugar chain suppresses not the triggering deprotonation but the succeeding denaturation. Biochim Biophys Acta 1993;1203:295-297.
4. Kishita M. Stability of granulocyte colony-stimulating factor (G-CSF) in serum. Clin Rep 1992;26:221-224.
5. Oh-eda M, Hasegawa M, Hattori K, et al. O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J Biol Chem 1990;265:11432-11435.
6. Pedrazzoli P, Gibelli N, Pavesi L, et al. Effects of glycosylated and non-glycosylated G-CSFs, alone and in combination with other cytokines, on the growth of human progenitor cells. Anticancer Res 1996;16:1781-1785.
7. Mire-Sluis AR, Das RG, Thorpe R. The international standard for granulocyte colony stimulating factor (G-CSF). Evaluation in an international collaborative study. Participants of the Collaborative Study. J Immunol Methods 1995;179:117-126.
8. Nissen C, dalle Carbonare Y, Moser Y. In vitro comparison of the biological potency of glycosylated versus non-glycosylated rG-CSF. Drug Invest 1994; 7:346-352.
9. Decleva E, Cramer R, Zabucchi G. Glycosylation improves the priming effect exerted by recombinant human granulocyte colony-stimulating factor (lenograstim) on human neutrophil superoxide production. Int J Tissue React 1995;17:191-198.
10. Martin-Christin F. Granulocyte colony stimulating factors: how different are they? How to make a decision? Anticancer Drugs 2001;12:185-191.
11. de Arriba F, Lozano ML, Ortuño F, et al. Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells. Br J Haematol 1997;96:418-420.
12. Schiodt I, Knudsen LM, Jensen L, et al. Flow cytometry comparison of CD34+ subsets in bone marrow and peripheral blood after priming with glycosylated or non-glycosylated rhG-CSF. Bone Marrow Transplant 1998; 21:1167-1169.
13. Saccardi R, Avanci G, Bezzini R, et al. Mobilization of PBSC for hematological rescue: comparison between glycosylated and non-glycosylated G-CSF 23rd Annual Meeting of the EBMT and 13th Meeting of the Nurses Group. Bone Marrow Transplant 1997;19(Suppl 1):S11.
14. Höglund M, Smedmyr B, Bengtsson M, et al. Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers - A comparative study. Eur J Haematol 1997;59:177-183.
15. Höglund M. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) - What is the difference? Med Oncol 1998;15:229-233.
16. Kopf B, De Giorgi U, Vertagen B, et al. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplant 2006;38: 407-412.
17. Dazzi C, Cariello A, Rosti G, et al. Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: A report of 34 cases. Bone Marrow Transplant 1999;23:529-532.
18. Olivieri A, Brunori M, Capelli D, et al. Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. Eur J Haematol 2004;72:10-17.
19. Höglund M, Smedmyr B, Simonsson B, et al. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 1996;18:19-27.
20. Watts MJ, Addison I, Long SG, et al. Crossover study of the haematological effects and pharmacokinetics of glycosylated and non-glycosylated G-CSF in healthy volunteers. Br J Haematol 1997;98:474-479.
21. Ings SJ, Balsa C, Leverett D, et al. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): Impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006;134:517-525.
22. Martino M, Console G, Irrera G, et al. Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim. J Clin Apher 2005;20:129-136.